TOP STORIES

• BUSINESS Shareholders Give Blessing to £46 Billion Shire Pact as Weber Touts US Foothold
  December 6, 2018

• BUSINESS Takeda Shareholders OK £46 Billion Shire Takeover
  December 5, 2018

• ORGANIZATION 9 EFPIA Companies Reviewed Headcount Planning after Drug Pricing Overhaul: Survey
  December 5, 2018

• BUSINESS Takeda Family Member Comes Forward for Final Appeal to Veto Shire Deal, but Admits Uphill Battle
  December 4, 2018

• BUSINESS With Current R&D Model Reaching Its Limit, Industry Going Digital to Boost Efficiency: Astellas Chairman
  December 3, 2018

• BUSINESS JT to Return Rights to Gilead’s 6 HIV Agents in 2019, Get 63.1 Billion Yen
  November 30, 2018

• BUSINESS Dissident Shareholder Group Hails Ex-Takeda Chief’s Opposition to Shire Deal
  November 29, 2018

• REGULATORY AMED Study Group Drafting Japan’s 1st Guidelines for Development of Recombinant Virus Vaccines
  November 29, 2018

• TRENDS Generic Industry at Crossroads: Companies Face Pressing Need to Boost Profitability ahead of FY2020
  November 28, 2018

• BUSINESS Keytruda Continues to Close in on Opdivo in July-September Global Sales
  November 27, 2018

• REGULATORY MHLW Proposes Introduction of Administrative Fines for Improperly Earned Revenues
  November 27, 2018

• BUSINESS Dissident Takeda Shareholders Making Final Pitch to Thwart Shire Buyout
  November 26, 2018

• REGULATORY MHLW Eyes Drastic Change to Cost Effective Analysis Flow, Enhanced Discussions Upfront
  November 22, 2018

• REGULATORY MHLW Proposes Quarterly Product Selections, Price Tweaks for CEA Scheme: Chuikyo
  November 22, 2018

• BUSINESS Pfizer’s ALK Inhibitor Lorbrena, Shire’s HAE Drug Now Available in Japan
  November 21, 2018

• BUSINESS Mitsubishi Tanabe Cuts FY2020 Targets in 5-Year Biz Plan on Flagging Royalty, Development Delay
  November 21, 2018

• BUSINESS 3 Japan Generic Majors Log 6% Growth in Combined April-September Sales despite Price Revision
  November 20, 2018

• BUSINESS 4 Major Wholesalers See 46.1% Increase in 1st Half Operating Profit due to Reductions in Yakkasa and SGA Costs
  November 19, 2018

• BUSINESS AstraZeneca Japan Set to Roll Out 4 New Treatments Every Year through 2021: Chief
  November 16, 2018

• REGULATORY Keytruda’s MSI-H Cancer Use Up for MHLW Panel Review Nov. 29; Wider Hemlibra Indication, 1st Line Tecentriq Also on Agenda
  November 16, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• …
• Next ›
• 最終 »